Adaptive Biotechnologies understands that each patient's situation is unique. We are committed to providing guidance and support during each step of the insurance process. That's why we offer the Adaptive Assist program: to help facilitate access to clonoSEQ testing services for patients who could benefit from the clinical insights provided by next-generation measurable residual (MRD) testing.

At Natera, we understand that some of our patients are unable to pay for our services due to financial hardship or other circumstances. That's why, through our Compassionate Care Program, patients who qualify will pay no more than $149 per test, and may owe nothing, depending on their financial situation.

PharmaEssentia SOURCE offers personalized support services designed to help you successfully start and stay on BESREMi (ropeginterferon alfa-2b-njft).

Our dedicated PharmaEssentia SOURCE Case Managers are here to help you:

• Answer any questions you may have
• Understand your insurance coverage
• Find resources for financial support

Call us at 800-700-5053 between 8:00 AM and 8:00 PM ET, Monday through Friday.